IOVA - Iovance Biotherapeutics, Inc.

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 51.28B
Enterprise Value 3935.51M
Trailing P/E N/A
Forward P/E 1-10.36
PEG Ratio (5 yr expected) 10.57
Price/Sales (ttm)N/A
Price/Book (mrq)4.38
Enterprise Value/Revenue 3N/A
Enterprise Value/EBITDA 6-9.55

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2017
Most Recent Quarter (mrq)Mar 31, 2018

Profitability

Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)-26.71%
Return on Equity (ttm)-44.25%

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
EBITDA -97.91M
Net Income Avi to Common (ttm)-97.89M
Diluted EPS (ttm)-1.38
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)297.08M
Total Cash Per Share (mrq)3.31
Total Debt (mrq)N/A
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)20.61
Book Value Per Share (mrq)3.27

Cash Flow Statement

Operating Cash Flow (ttm)-77.75M
Levered Free Cash Flow (ttm)-39.28M

Trading Information

Stock Price History

Beta 2.95
52-Week Change 3131.20%
S&P500 52-Week Change 313.59%
52 Week High 319.90
52 Week Low 34.45
50-Day Moving Average 313.58
200-Day Moving Average 314.76

Share Statistics

Avg Vol (3 month) 3928.49k
Avg Vol (10 day) 3661.48k
Shares Outstanding 589.64M
Float 64.61M
% Held by Insiders 11.54%
% Held by Institutions 192.99%
Shares Short (Jun 15, 2018) 45.02M
Short Ratio (Jun 15, 2018) 43.83
Short % of Float (Jun 15, 2018) 46.21%
Short % of Shares Outstanding (Jun 15, 2018) 45.60%
Shares Short (prior month May 15, 2018) 45.03M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 21/100
Last Split Date 3Sep 26, 2013